Comprehensive Vascular Review Course
Third Annual Comprehensive Vascular Review Course
October 25-26, 2013 | InterContinental Chicago O’Hare Hotel | Rosemont, IL
Please note: All participants must pre-register prior to the program date. Space is limited and on-site registration may not be available. Online registration will open in June.
The Society for Vascular Surgery® (SVS) is pleased to introduce the third annual Comprehensive Vascular Review Course. This educational activity is an intensive two-day vascular surgery review course designed to help practicing vascular surgeons update their knowledge base.
The faculty consists of vascular surgeons with extensive expertise in their respective fields. The course will include didactic lectures, review of VESAP questions, attendee interaction with audience response systems, and a panel for questions and answers.
SVS Members: $1,050
All registrants will be allowed to purchase VESAP2 for $300, a special price that is only available at the time of registration.
Upon completion of this educational activity, participants should be able to:
1. Identify the complete spectrum of vascular disease treated by the modern vascular surgeon
2. Apply basic evaluation and management for uncommon vascular disorders
3. Manage self-assessment and questions regarding current therapy for modern vascular disease
Who Should Attend?
This course is intended for vascular surgeons seeking recertification in vascular surgery and for those seeking a comprehensive update in all areas of vascular surgery.
The Society for Vascular Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
The Society for Vascular Surgery designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
the course schedule for the Comprehensive Vascular Review Course.
- William D. Jordan, Jr., MD, University of Alabama School of Medicine, Birmingham, AL
- Cynthia K. Shortell, MD, Duke University Medical Center, Durham, NC
- Kenneth J. Cherry, MD, University of Virginia, Charlottesville, VA
- Michael C. Dalsing, MD, Indiana University, Indianapolis, IN
- Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX
- Steven Dean, DO, The Ohio State University Medical Center, Columbus, OH
- John R. Hoch, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
- Jeffrey H. Lawson, MD, PhD, Duke University Medical Center, Durham, NC
- Alan B. Lumsden, MD, Methodist DeBakey Heart Center, Houston, TX
- Tara M. Mastracci, MD, Cleveland Clinic, Cleveland, OH
- Robert B. McLafferty, MD, Southern Illinois University School of Medicine, Springfield, IL
- George H. Meier, MD, University of Cincinnati School of Medicine, Cincinnati, OH
- Ross Milner, MD, The University of Chicago Medicine & Biological Sciences, Chicago, IL
- Richard Neville, MD, The George Washington University, Washington, DC
- Joshua O'Brien, MD, Duke University Medical Center, Durham, NC
- Marc A. Passman, MD, University of Alabama at Birmingham, Birmingham, AL
- Benjamin J. Pearce, MD, The University of Alabama at Birmingham, Birmingham, AL
- Todd E. Rasmussen, MD, US Army Institute of Surgical Research, Fort Sam Houston, TX
- Ravi K. Veeraswamy, MD, Emory University School of Medicine, Atlanta, GA
- Thomas W. Wakefield, MD, University of Michigan Medical Center, Ann Arbor, MI
Disclosure statements have been requested from the faculty and will be made available at the conference. All faculty presenters are expected to disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products and/or medical devices during their presentations.
SVS Staff Disclosure
SVS staff associated with the development of this activity has nothing to disclose.
Video and Audio Recording Policy
Video or audio recording of any session is not permitted.
The SVS Comprehensive Review of Vascular Surgery is not affiliated with or sanctioned by the Vascular Surgery Board of the American Board of Surgery.
Updated May 2013